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EPIDEMIOLOGICAL COMPARISON OF NSALD AND ORAL 
ENZYMES IN OSTEOARTHRITIS AND OTHER RHEUMATIC 
DISEASES 
W Schiess ~, C Conradt 2 
~Clinical Research, Mucos Pharma, Geretsried; 2Department 
Medica/ Biometrics, University Clinic Heide/berg; Germany 
To establish the safety and efficacy of an oral enzyme-combina- 
tion product (OE) in the treatment of rheumatic diseases a 
retrolective cohort study with parallel groups was undertaken as 
an epidemiological study, in which the enzyme combination was 
compared with nonsteroidal anti-inflammatory drugs (NSAID). 
Data of 1426 patients treated for rheumatic diseases were regis- 
tered by 203 physicians. Data on age, gender, indication for treat- 
ment (diagnostic group), anamnestic data (especially pre-treat- 
ment), complaints at the beginning and end of treatment, treat- 
ment duration, prescribed drugs (OE, NSAID), additional treat- 
ment and adverse events were collected. Included in the efficacy 
analysis were 884 patients which were treated either only with OF 
(N513) or only with NSAID (N=371) and could be classified unam- 
biguously into one of the following diagnostic groups: osteoarthri- 
tis (joint diseases, spinal diseases), rheumatic soft issue dis- 
eases, rheumatoid arthritis. 
As clinically relevant and reliably evaluable criterion freedom from 
rheumatic complaints at the end of treatment was considered. 
For evaluation of safety the documented adverse events of all 
patients were considered. Patients of the control group were 
treated with the recommended symptomatically effective doses 
of NSAID. 
As the allocation of the compared treatment options (OE or 
NSAID) to the patients was not randomized, a mixing of treatment 
effects with other factors cannot be excluded. For adjustment of 
these confounding factors two methods were applied: a) logistic 
regression of the relative ratio of the main criterion and all con- 
founding factors and b) stratification of data according to the 
propensity score i.e. the probability of a treatment with OE. Both 
methods yielded similar results: A 80% higher success rate can 
be expected in total for OE than for NSAID at comparable initial 
and treatment situations (95% confidence interval with logistic 
regression = 1.26-2.59, with stratification according to propensi- 
ty score = 1.25-2.52). 
OF were well tolerated showing much less adverse events when 
compared with conventional doses of NSAID. 
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ROLE OF VASCULAR AND HAEMATOLOGICAL ABNORMAL- 
ITIES IN OSTEOARTHRITIS (OA)- RATIONALE FOR USE OF 
PENTOSAN POLYSULPHATE AND GLUCOSAMINE I CHON- 
DROITIN SULPHATE 
PA Cheras, GVL Nielsen, EA Blackwell HK Outerbridge, S Fine 
Osteoarthritis Research Group, University of Queensland, 
Greenslopes Private Hospital, 
Brisbane, Australia 
Vascular and haematological factors (balance between coagula- 
tion and inflammation) inOA provide a conceptual framework that 
explains the histological, biochemical physiological and clinical 
aspects of the disease and suggest a role for normalization of 
haemostasis in OA treatment. 
Aim: To assess the influence of calcium pentosan polysutphate, 
(CaPPS) and glucosamine hydrochloride / chondroitin sulphate, 
(GHCS) on coagulation, fibrinolysis and clinical outcomes in OA. 
Methods: Case control pilot study 1, (n=8), oral CaPPS 10mg/kg 
was given twice weekly for 4 weeks, followed by 12 weeks wash 
out. This scheme was repeated twice. Case control pilot study 2, 
(n=4), oral GHCS (1 .5g glucosamine HCI and 1 .2g chondroitin 
sulphate) was given daily for 9 weeks. For study 1 and study 2, 
blood sampling for measures of procoagulant tendency and fibri- 
nolysis and clinical assessment (WOMAC) were performed at 
commencement and completion of the treatment periods. 
Results: Study 1. Baseline vs treatment (for first, second and 
third treatment periods respectively). PPS reduced procoagulant 
tendency; platelet aggregation response decreased (80 vs 73%), 
(77 vs 63%), (84 vs 72%) and Fg fell marginally (2.9 vs 2.8 g/I), 
(2.8 vs 2.7 g/I), (3,1 vs 2.7 g/I). Fibrinolysis was enhanced; ECLT 
decreased (190 vs 175 mins), (212 vs 151 mins), (206 vs 152 
mins), and PAl-1 activity fell (19 vs 12.9 IU/ml), (20.6 vs 18.9 
IU/ml), (15.1 vs 10.8 IU/ml). WOMAC score decreased, consistent 
with improved clinical outcome; (65 vs 41), (39 vs 25), (29 vs 24). 
GHCS also decreased procoagulant indicators; platelet aggrega- 
tion response (83 vs 73%) and Fg (3.5 vs 3.0 g/I). Fibrinolysis was 
enhanced, ECLT normalized (173 vs 130 mins) and alpha 2 
antiplasmin fell (91 vs 75%). Clinical outcome improved, WOMAC 
(45 vs 30). 
Conclusions: PPS and GHCS decreased procoagulant tenden- 
cy and improved fibrinolysis coincident with improved WOMAC 
score, suggesting a role for normalization of haemostasis in clin- 
ical outcome. 
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RADIOGRAPHIC SEVERITY OF KNEE OSTEOARTHRITIS IS 
HIGHLY CORRELATED WITH FUTURE PROGRESSION OF 
THE DISEASE 
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Objective: To investigate the impact of baseline radiographic 
severity of knee osteoarthritis (OA) on the long term rate of joint 
space narrowing. 
Design: Three-year andomized, placebo-controlled, prospective 
study, of 212 patients with knee OA, recruited in an osteoarthrit- 
ic outpatient clinic and having taken part in a study evaluating the 
effect of glucosamine sulfate on symptom and structure modifi- 
cation of knee OA. 
Material and Methods: Measurements of mean joint space 
width (JSW), assessed with a computer assisted method, and 
minimum JSW, assessed with a graduated magnifying lens, per- 
formed at baseline and after 3 years from weightbearing antero- 
posterior knee radiographs. 
Results: Baseline mean and minimum JSW were significantly and 
negatively correlated with the percentual joint space narrowing 
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observed after 3 years (r = -0.34, p = 0.003 and r = -0.30, p= 0.01, 
respectively). In the lowest quartile of baseline mean JSW (< 4.5 
mm), the JSW even increased by 3.8 % (23.8) after 3-year in the 
placebo group and 6.2% (17.5) in the glucosamine sulfate group, 
although the difference between the two groups in these severe 
case was not statistically significant (p= 0.70). In the highest 
quartile of baseline mean JSW (> 6.2 mm), a joint space narrow- 
ing of 14.9 % (17.9) occurred in the placebo group while patients 
from the gtucosamine sulfate group only observed a narrowing of 
6.0 00 (15.1) after 3-years. Patients with the most severe OA at 
baseline had a RR of 0.42 (0.17 - 1.01) to experience a 0.5 mm 
joint space narrowing over 3 years, compared to those with the 
less affected joint. Glucosamine sulfate effect on joint space nar- 
rowing was borderline significant (p = 0.10) in the patients with 
mild OA in the highest quartile of baseline mean JSW. 
Conclusion: These results suggest that patients with the less 
severe radiographic signs of knee osteoarthritis will experience, 
over 3 years, the most dramatic disease progression in terms of 
joint space narrowing. Glucosamine sulfate appears to be partic- 
ularly beneficial in such patients, by reducing the rate of joint 
space narrowing by 55%. 
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ECONOMIC BURDEN ANALYSIS OF OSTEOARTHRITIS 
IN THE UNIVERSITY OF THE PHILIPPINES-PHILIPPINE 
GENERAL HOSPITAL 
RN Eullaran, EG Penserga 
University of the Philippines Genera/Hospital, 
Malate, MM 
Introduction: Osteoarthritis is the most common of all joint dis- 
eases, causing significant economic burden, much of which are 
data from western and developed countries. In the Philippines, 
urban data and anecdotal reports point to a high prevalence of 
osteoarthritis locally. With the projected population of the 
Philippines this year at 76 million, an estimated 3.1 million 
Filipinos will be suffering from osteoarthritis, based on the COP- 
CORD-ILAR study prevalence of 4.1%. In a large public tertiary 
hospital like UP-PGH, medical services are free but direct and 
indirect costs to both patients and government is unquantified. 
Results of economic burden analysis like this aims to improve the 
quality of clinical and financial decision making on the part of 
health planners and treating physicians by providing information 
on the overall cost of treatment. This is a preliminary report. 
Objectives: This paper seeks to quantify prospectively the 
direct and indirect costs associated with the care of uncompli- 
cated osteoarthritis in the University of the Philippines-- 
Philippine General Hospital Out Patient Arthritis Clinic, looking 
into its effects on the patient and society. 
Methods: A standard questionnaire was designed to include clin- 
ical data and the direct and indirect costs incurred by patients. A 
model was constructed based on Rheumatology consultants and 
Rheumatology fellows in training manning the clinic. The patient 
perspective included costs that were borne by the family includ- 
ing personal non-medical costs and productivity costs. All costs 
were expressed in Philippine peso, which is 50 pesos to a US dol- 
lar. 
Results: An assumption was made that 401,800 people with 
osteoarthritis from the National Capital Region (total population of 
9.8 million) will be seen per year in our clinics. The estimated total 
annual direct and indirect cost of treating an individual patient 
with osteoarthritis is P 8,278.00 or P 3,400,847, 919.23 for the 
National Capital Region. The cost of drugs contributed the 
largest, comprising 71% of the total annual cost. Laboratory 
examinations amounted to P 526,358,000.00 or about 15% of the 
total annual cost. Among the indirect costs, lost wages amount- 
ed to P 301,350,000.00 or about 8.8 %. 
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CLINICAL EFFECTS AND POSSIBLE MECHANISMS OF GLU- 
COSAMINE IN THE TREATMENT OF OSTEOARTHRITIS 
H Nakamura, K Masuko-Hongo, T Kato, K Nishioka 
Institute of Medical Science, St Marianna University, Kawasaki, 
Japan 
Aim: Glucosamine has been used for arthritis as a supplement. 
Many clinical studies have shown that glucosamine was effective 
for treatment of OA. Some in vitro experiments using chondro- 
cytes were reported; however the mechanism is still unclear. The 
objective of this study is to ascertain the efficacy of glucosamine 
on OA and elucidate its mechanism. 
Method: (1) Clinical study; 40 OA patients with 62 knees were 
administered with glucosamine preparation (1500mg/day) after 
informed consent. Knee score, VAS, Face scale and clinical 
symptoms were assessed for 3 months. Age matched 15 OA 
patients with 25 knees were used for control. Serum sample was 
collected before and after the treatment. The concentration of 
YKL-40, PGE2, NO and titer of anti type II collagen antibody 
(COLllab) were mesured in serum. (2)In vitro study: PGE2, NO, 
MMP-1, 3, 13 and TIMP-1 concentrations were detected in the 
supernatant of IL-1 stimulated human chondrocytes. 
Results: Knee score, VAS, Face scale as well as clinical symp- 
toms improved after the administration of glucosamine, while no 
improvement was found in the control group. Serum PGE2 con- 
centrations and titer of anti COLIlab decreased after the treat- 
ment. Serum YKL-40 concentrations showed no difference, how- 
ever, strong relationship was found between YKI40 and the stage 
of OA. In in vitro studies, glucosamine suppressed the production 
of PGE2, NO and MMP-1 in a dose dependent manner. 
Conclusion: Glucosamine preparation was effective for OA treat- 
ment clinically and the possible mechanism was suggested to be 
anti-inflammatory, immune modifying and chondroprotective 
effects. 
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IMPINGEMENT CAUSES SIGNS OF CARTILAGE 
DEGENERATION AT THE HIP JOINT PERIPHERY 
IN YOUNG ADULTS 
S. Wanner -_,1 W. Hoistetter 2 , M. Chiquet 3 ,K. A. Siebenrock 2
7 Department of Clinical Research. Group for Bone Biology, 
University of Berne, Switzerland; 
2 Department of Orthopedic Surgery, University of Berne, 
Inselspital, Switzerland; 
3 M.E. Muller Institute, University of Berne, Switzerland 
Aim: An impingement mechanism between the anterior femoral 
head/neck junction and the acetabular im is hypothesized as a 
cause for early osteoarthritic hanges in young adults. This 
mechanism is thought to initiate cartilage lesions on the femoral 
head outside the main weightbearing area by mechanical force. 
We have examined the impinged tissue from the femoral 
head/neck junction histologically and then characterized it on a 
molecular basis. To understand the pathogenesis of this tissue, it 
was compared with healthy and to osteoarthritic artilage and 
examined for signs of osteoarthritis. 
Methods: Impinged (n=14) and osteoarthritic (n=9) cartilage 
biopsies were obtained intraoperatively, healthy cartilage from 
age matched deceased persons (n=6). All tissue samples were 
fixed in paraformaldehyde, decalcified in EDTA, and embedded in 
paraffin. 
Results: Histology according to Mankin criteria revealed signifi- 
cant differences between impinged and healthy cartilage, sug- 
gestive of degenerative changes. By immunohistology increased 
levels of COMP and tenascin, two proteins known to be upregu- 
